Trial intelligence / Profile preview

SMART02 valproic acid in childhood-onset spinal muscular atrophy

jRCT2091220231Completed

Sponsor
Institute of Medical Genetics, Tokyo Women's Medical University
Start
Dec 2015
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial in spinal muscular atrophy (SMA) comparing Valproic acid (SMART) arm with Placebo arm (2 arms). Primary endpoint: HFMSE score. Started Dec 2015; status: completed.

02

Drugs

valproic acid
03

Conditions

spinal muscular atrophy (SMA)

Beyond the preview

Go deeper on jRCT2091220231.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on jRCT2091220231.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call